Phillips Brooks House Association (PBHA) and Breakthrough Greater Boston (BTGB) , both based  in Cambridge,  have together raised more than $50,000 for vital summer youth programs, according to a recent communique from BTGB.

Sponsored by The Boston Foundation, the Giving Common Challenge was a 36-hour online event running from 8:00 a.m. on October 10 through 8:00 p.m. on October 11, 2012. More than 500 Massachusetts nonprofits competed for donations and more than $100,000 in time-based and grand prizes based on both the number and amount of unique gifts were given out. Both PBHA and Breakthrough took home major prizes.

Cambridge’s PBHA won the “most unique donors” grand prize of $25,000, with 379 supporters contributing $17,102 to the organization. PBHA also won one of the $2,000 “happy hour” prizes, awarded to the first 10 nonprofits to receive 50 unique gifts between 6:00 and 8:00 p.m. on October 10. Combining the amount raised from donors with the two prizes, PBHA raised a total of $44,102.

Breakthrough Greater Boston, also based in Cambridge, finished in 9th place in unique donors, after rising as high as 4th. With its 137 gifts, as well as a $2,000 “lunch time” prize similar to PBHA’s “happy hour” prize, Breakthrough Greater Boston netted close to $15,000.

The funds raised by PBHA will support more than 80 community-service programs led by 1,600 college students in the areas of adult services; advocacy, organizing, housing, and health; after-school and in-school; mentoring; and summer.

PBHA executive director Maria Dominguez Gray noted, “The breadth and support of the individual donors, from former teen participants to volunteer alumni, was overwhelming. The additional funding we were able to raise through this important community effort is especially important in light of recent government cuts to high-impact services, including PBHA’s Harvard Square and St. James homeless shelters as well as the Summer Urban Program.” PBHA’s student president Carolyn Chou confirmed, “This money will allow us not only to continue providing quality services but imagine an exciting future for PBHA. The dedication and support of our donors is a testament to the work we do, and it will allow us to keep going despite a tough financial environment for nonprofits.”

The impact on Breakthrough Greater Boston’s out-of-school time and teacher training programming will be equally great,  according to  Breakthrough’s executive director, Elissa Spelman.

“As we continue to work on bridging the education gap in Greater Boston, we rely on the generosity of our supporters. Placing 9th in the Giving Common Challenge is not only an honor for our organization but a testament to the dedication of the broader Breakthrough community that made our success over the past 36 hours possible,” she said.  “Breakthrough Greater Boston is in the midst of an exciting expansion from Cambridge into Boston, so the awareness and visibility of our organization within Boston’s philanthropic community couldn’t come at a better time. We extend our sincerest gratitude to all who supported us.”

According to the BGTB communique: For more than a century PBHA programs have provided vital experiences for generations of leaders in service and activism while developing real, meaningful community partnerships. PBHA strives to create change on multiple levels in Boston and Cambridge. For 20 years BTGB  has been working to transform urban education for students and teachers.. Through six years of intensive, tuition-free, out of school time programming, Breakthrough changes students’ academic trajectories and supports them along the path to four-year college. Simultaneously, BTGB builds the next generation of teachers through competitive recruitment, research-based training, and coaching from master teachers.

–Posted by Anita M. Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning public relations and online marketing  firm based in Cambridge, MA.

PRESS RELEASE

· New antibody program targets Tau protein, a major cause of Alzheimer’s disease

· License agreement potentially worth more than Swiss Francs 400 Million (approximately USD 418 million*)

Lausanne, Switzerland, 18 June, 2012 – AC Immune SA, today announced that it has entered into a second exclusive worldwide license agreement and research collaboration with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases.

Under the terms of the agreement, AC Immune will receive an undisclosed upfront payment and is eligible to receive research, development and commercialization milestone payments totaling more than Swiss Francs 400 million (approximately USD 418 million*) for Alzheimer´s disease and other indications. Additionally, AC Immune is eligible to receive royalties on net sales of products resulting from the collaboration. Under the multi-year joint research collaboration, AC Immune will work in partnership with Genentech to identify and formulate several pre-clinical candidates. Genentech will have global responsibility for pre-clinical and clinical development, manufacturing and commercialization of antibodies resulting from the collaboration.

Prof. Andrea Pfeifer, CEO of AC Immune said: “We are delighted to continue our excellent relationship with Genentech through this second landmark deal to fight Alzheimer’s disease. This underlines Genentech’s trust in AC Immune’s proprietary technology platform and we are confident in our joint abilities to develop not only
first-in-class but also best-in-class medication for one of the biggest healthcare problems of this century.”

“This second licensing deal gives us financial security to continue AC Immune’s
world-leading efforts to develop disease modifying therapies and diagnostics. We are now recognized as having one of the broadest and most advanced Alzheimer’s pipelines in the industry”, remarked Martin Velasco, Chairman of The Board of AC Immune .

Commenting on the deal, James Sabry, Genentech’s Vice President of Partnering , said: “Genentech is committed to bringing innovative treatments to patients suffering from devastating neurodegenerative diseases, and is developing a number of approaches to tackle Alzheimer’s disease. The addition of this anti-Tau program to our CNS pipeline complements other approaches we are investigating, including crenezumab which we in-licensed from AC Immune in 2006.”

About the anti-Tau Program

The Tau protein forms twisted fibers inside brain cells and build tangles that are considered by many in the scientific community as the second major cause of Alzheimer’s disease besides Abeta-plaques. The anti-Tau antibodies were discovered and humanized by AC Immune through its proprietary SupraAntigen TM technology.

“The anti-tau-antibodies have proven highly specific to misfolded Tau in relevant animal models for Alzheimer’s disease and are therefore well suited to be developed as a disease-modifying drug. This has significant potential as there are at present no known cures for Alzheimer’s disease,” said Dr. Andreas Muhs, Chief Scientific Officer
of AC Immune .

About Crenezumab

An anti-Abeta antibody, crenezumab was discovered and humanized by AC Immune. It is designed to bind to amyloid beta (Abeta), the main constituent of amyloid plaque in the brains of patients with Alzheimer’s disease. Abeta is considered to be a major cause in the development of the disease. Genentech is currently evaluating crenezumab in a Phase II clinical study in Alzheimer’s patients with mild to moderate symptoms. At the time the deal with Genentech was announced in December 2006, it was stated to have a potential total value of more than USD 300 million in clinical and regulatory milestone payments to AC Immune, excluding royalties.

In May 2012, crenezumab was selected to be tested in the world’s first-ever prevention trial in healthy individuals who are genetically destined to develop Alzheimer’s disease. This landmark study to investigate whether an anti-amyloid treatment can stave off the disease is being run by the US National Institutes of Health (NIH), the Banner Alzheimer’s Institute (BAI), the University of Antioquia in Colombia and Genentech.

About Alzheimer’s Disease

Alzheimer´s is the most common form of dementia. It is degenerative, irreversible and terminal. The memory and thinki ng of the patients is progressively destroyed. Besides the personal aspect there is a huge social and economic impact. Alzheimer´s disease is recognized as a significant health crisis of the 21st century with currently more than
36 million patients worldwide. This number is expected to double in the next 20 years and to triple to more than 116 million by 2050. In 2010 global worldwide costs were estimated to be USD 604 billion and were exceeding 1% of the global domestic product (Reference: World Alzheimer Report 2011, Alzheimer’s Disease International).

Scientists don’t yet fully understand what causes Alzheimer’s disease, but it has become increasingly clear that it develops because of a complex series of events that take place in the brain over a long period of time. Two proteins – Tau and Abeta – are perceived as the major causes of neurodegeneration: tangles and other abnormal forms of Tau protein accumulate inside the brain cells, while plaques and oligomers formed by Abeta occur outside the brain cells of people with Alzheimer’s disease.

About AC Immune SA
AC Immune SA is a Swiss-based biopharmaceutical company and a leader in Alzheimer´s disease drug development. AC Immune develops innovative therapeutics with “best in class” potential against Alzheimer´s disease and other conformational diseases along three axes: vaccines, antibodies and small molecules. The anti-Abeta antibody (crenezumab) for passive immunization is partnered with Genentech and is in Phase II development. The company continues to develop in house the small molecule ACI-91 and the vaccine ACI-24 in Phase II and Phase I/IIa clinical development respectively. These three clinical programs are focused on Alzheimer’s disease, and are backed by a rich portfolio of preclinical compounds. The therapeutic molecules are also leveraged for Alzheimer´s disease diagnostic and other central nervous system and non-CNS diseases, such as Glaucoma. Since its foundation in 2003, AC Immune has raised CHF 64 million from private investors.

-Anita M. Harris
Disclosure: I will be working with AC Immune at the Biotechnology Industry Organization today in Boston.

New Cambridge Observer is a publication of the Harris Communications Group, an award-winning strategic public relations,  marketing communications and thought leadership firm in Cambridge, MA.

For entrepreneurs seeking venture capital funding, there’s good news—and there’s bad news. The good news is that  it’s easier now than at any time in the last ten years to get relatively small amounts of seed money. The bad news is that it’s harder to obtain “A Round” or additional series funding after that.

That was the consensus of  three Boston area venture capitalists who spoke at the Cambridge Innovation Center on  Wednesday, May 2.  Moderator Ben Hron of  law firm McCarter -English, which sponsored the event, asked the VCs  how the 2008 economic downturn  has impacted the VC industry;  where things stand now,  and what they foresee for the future.

Impact of the recession
A changing industry
Jo Tango, founder and partner of Kepha Partners, which invests in early stage companies, said that for many VC firms, this is a period of innovation. “We call it VC 2.0,”  he quipped to the audience of  entrepreneurs.  The VC industry, which started in about 1980, used to be dominated by approximately 20 major firms; today, there are more smaller, more specialized VC firms, he said.

David Beisel, co-founder and partner of  NextView Ventures, a dedicated seed-stage venture capital firm focused on Internet startups, said that the downturn has “facilitated a  maturation process,” which he likened to what happened in the beer industry in the 1990s.

That is, “You had to be either one of the biggest, like Anheuser-Busch—or a microbrewery.” Mid-size companies like Genesee fell by the wayside.

Likewise,  today,  he said, “VC firms are no longer trying to be all things to all entrepreneurs; they’re taking a dedicated approach.  Recently, four or five firms raised more than $1B but mid-sized firms are struggling.”

CA Webb, Executive Director of the New England Venture Capital Association, said that considering this a time of “introspection and innovation” is “optimistic…The reality is that the industry is taking a hard look at itself. Some say that the ‘sky is falling,’ because there’s less money being invested; this means that some firms will shut down. Those that succeed will need to articulate clearly just what they are willing to offer and to whom.”

Tango pointed out that “Innovation [in the VC industry] creates a challenge for entrepreneurs because VC firms are “all over the map,” and “it’s difficult to know which one is right for [a particular startup]. It’s easier now to get seed money–but terms are often more difficult to distinguish.”

Current trends
In asking the panelists for their views on the current venture funding situation, Hron shared Q1 2012 statistics showing  a large number of deals but a drop in total funding compared with previous quarters– in indicating fewer “megadeals.”  “Should entrepreneurs should be optimistic because of the number of deals or pessimistic about the size of the deals?” he asked.

Fewer large deals
Tango responded that one reason for the decline in large deals has to do with the number of deals VCs have previously closed.  In the current economic climate, he explained, it’s difficult raise a stream of money. In a recent study of five VC Web sites, his firm found that many VCs are already sitting on the boards of 10-17 companies in which they have invested. “If you’re fundraising…if you’re already on 15 boards, you need to spend your time fund raising,” not sitting on additional boards.

Smaller investments
Beisel described what he called a longer term trend:  in some sectors, especially digital media, companies don’t need to raise as much money for initial funding as in other sectors–so at earlier stages, the venture community is reacting by not writing $5M checks but rather $1M or .5 M.

In Webb’s view, “seeding is now like the old Series A funding: there is a lot of seed money to go around but Series A is now looking like the old series C “(IE–difficult to come by).

Follow-on funding can be problematic.
Tango agreed –describing a firm that backed 20 companies with seed money but told him it will provide only 2 % of those with Series A funding.  He added that the situation is even more complicated because even at the “seed stage,”different VCs require different terms.

In fact, he recommended, “Ninety per cent of startups should be bootstrapped (funded by self, friends and family) because other investors expect that they will get their money out within a few years. “With VC funding, you’re becoming a fiduciary…taking on ‘credit card debt’ that you will need to pay back.”

In Beisel’s view, before taking any money from VCs, an entrepreneur needs to know how outsiders view the firm, the reputation of the VC firm, which partner will be best for the company, and whether the firm usually adds to series funding or “will you be one of the 98% that get dropped?”

Health care vs. other  investment
Citing a decline in financing for health care ventures in Massachusetts compared with increased financing for Internet and mobile technology, Hron asked if investors are seeking short-term gains as instead of  taking the long view required for biotechnology and pharma payback.

Webb responded that one reason for the slowdown in health care company funding is that the US Food and Drug Administration is taking longer to approve products so the horizons for investors are longer. As a result, investors are shifting toward healthcare technology, “big data” and products that will bring a quicker return.

In Beisel’s view, “Over the last ten years the returns for health care investment have not been that great; health care is now even more challenging. But VCs won’t shift to other spaces; the money just won’t get raised.”

Long -term trends
According to Hron, the data suggest a rise in VC investing in Washington State, Texas, and Illinois. “Are we seeing the rise of a national VC community or is this a blip?” he asked. “And will VC investors look at companies nationwide?”

Tango and Beisel agreed that large investors are looking at companies nationally and internationally–especially in the Internet space.

They also agreed that it’s unlikely that VCs will spring up in Kansas or in “third-tier American cities,” as Beisel; put it.  In Tango’s view, “they will still be centered in Boston, NY and California.”  Beisel pointed out that that VC firms are on the rise in nations like Argentina and Eastern Europe.  According to Webb, “Capital clusters around academic institutions: You won’t see much density elsewhere.”

Crowd sourcing
Regarding the  recent passage of legislation allowing corporate fundraising through crowd sourcing, panelists expressed concerns about possibilities for fraud and entry of organized crime; and also  that unsophisticated investors might not know that seasoned professionals expect to lose money on most  investments—in hopes that a few will have big payoffs.

Asked by Hron if VCs will look askance at companies raising initial funding through crowd sourcing, Beisel said  that it’s fine to get seed money wherever you can but a “real company” will need institutional investors in order to grow large.

In Tango’s view, “Your source of funding depends on what you want to accomplish: Do you just want to get money…or are you looking for series of VC rounds, advice and support?”

PANELIST BIOs

David Beisel – David is Co-Founder and Partner of NextView Ventures, a dedicated seed-stage venture capital firm focused on investments in internet startups.  Previously he was an investor at both Venrock and Masthead Venture Partners, where he served on the boards of BlogHer and Gazelle.  Prior to joining Masthead, he co-founded Sombasa Media, an e-mail marketing company which was successfully acquired by About.com and subsequently became a division of Primedia (NYSE: PRM), where he served as Vice President of Marketing.  He is also the founder of the Web Innovators Group, a quarterly entrepreneur-focused event which attracts nearly a thousand attendees.  David blogs atwww.GenuineVC.com.

Jo Tango – Jo is Founder and Partner of Kepha Partners, an early-stage venture capital firm.   Previously, Jo spent was a General Partner at Highland Capital Partners, where he worked for nearly nine year, and before that he spent five years with Bain & Company.  Jo has invested in the e-commerce, search engine, Internet ad network, wireless, supply chain software, storage, database, security, on-line payments and data center virtualization spaces.  He has been a founding or first institutional investor in Azuki Systems, Bit9, ExaGrid, StreamBase Systems, Vertica Systems (acquired by Hewlett-Packard), Virtual Iron (acquired by Oracle) and VoltDB, getting involved nearly always at the company inception phase. Other investments include Ask Jeeves (Nasdaq: ASKJ), Digital Market (acquired by Agile Software), and NextCard (Nasdaq: NXCD).

C.A. Webb – C.A. became the Executive Director of the New England Venture Capital Association in January 2012.  Members of the NEVCA include more than 700 venture capital professionals from over 100 firms that collectively manage more than $50 billion in capital.  C.A. has spent her career in entrepreneurial roles with mission driven, early stage and high growth organizations. Her work has focused on breakthrough business models in a diverse array of industries including retail and packaged goods (Whole Foods Market), consumer internet technology (Care.com), sustainability (Preserve Products), historic preservation (Trinity Boston Foundation), public education (Boston Collegiate Charter School), and publishing (Fast Company magazine

Tim Rowe, CEO of the Cambridge Innovation Center in Kendall Square, gave a great talk at HarrisCom Group’s recent Pitching for Business Workshop on Feb. 23.  Among his main points: “Elevator pitching is like dating:” the goal is to find out if it’s worth spending more time with the person you’re speaking to. Tim is also a venture capitalist and president of the Kendall Square Association in Cambridge, MA.

Here are links to the video and to the blog I wrote on the HarrisCom Web site.

Link to video
Link to blog  

–Anita M. Harris
Anita M. Harris is president of the Harris Communications Group of Cambridge, MA, an award-winining public relations 3.0 firm specializing in strategic integrated marketing communications and thought leadership  for clients in health, science, energy, technology and education, worldwide. 

Speaking at the British Consulate in Kendall Square, last week,  Morgan Stanley Chief Market Strategist David Kelly predicted slow (3%) growth for the US economy in 2012–unless  there are no major disruptions  like  last year’s  Arab Spring, the European Debt Crisis,  the Tsunami in Japan or  what he termed a “home grown” crisis like the one created when Congress allowed this country to hover on the brink of default rather than raise the debt ceiling.

While the deficit is cause for concern, he said, a default would have thrown the nation into a true “great depression.” In diminishing its debt,  the US should proceed slowly. Both tax and entitlement reforms are needed, he said, and moving bit by bit can lead to a balanced budget within 7 years (?) whereas trying to change everything all at once could lead to disaster.

Despite the crises of  2011,   he pointed out, the Standard and Poor’s Index ended up  just .003 percent lower than it had been  at the year’s start. The coming year will  be one of uncertainty, but “the US economy can grow through that, ” he said.

According to Kelly,   factors in several areas will  likely lead to growth:

Housing:
-The  current very low level of housing starts, low inventories and  rising rents will lead to greater demand for homes, especially as consumer finances continue to improve.

-With mortgage rates at 3.8 percent, consumers are refinancing their homes, which means that consumers now have 14% disposable income, compared with 11% in 2007.

-This is the most affordable housing market “ever. ” Mortgage payments now account for  just 10 percent of average household income–which means that people have more money to spend elsewhere.

Automobile:  

-The age of the average vehicle in the US has risen from 9.8 several years ago to ten years;  as cars break  down, sales will go up.

Capital Spending
-Companies have held back on capital spending; as confidence rises,  spending will increase.%.

The key to it all, he emphasized, is confidence that the economy will improve.  Still, he said, he wished that  Ben Bernacke and the Federal Reserve Bank would take the year off “to work on their golf game” instead of telling people that interest rates will remain low for the next few years–which encourages people to put off spending.  What is more, he said,  keeping interest rates low will discourage banks from lending–because they do not want to be locked in to low rates for thirty years, when they know that rates are likely to rise a few years from now.

A link to Morgan Stanley’s  Guide to the Markets for Q1 2012     is available at

https://www.jpmorganfunds.com/cm/Satellite?pagename=jpmfVanityWrapper&UserFriendlyURL=insidemarket_browsetheguide

—Anita M. Harris

New Cambridge Observer is a publication of the Harris Communications Group, a strategic PR firm specializing in integrated marketing communications, thought leadership,  media relations and social media for companies in health, science, technology and energy, worldwide. 

 Local AFL-CIO Insulators, Tin Kinockers and Pipefitters from Cambridge Local  use a large inflatable rat to make clear how they feel about the use of non-union, non-Cambridge workers by PH Mechanical for work currently underway at 302 Third Street in Kendall Square.  “They don’t conform to community standards; they are unlicensed, and they have no apprentice program,” said one union member who declined to give his name. He said he expects that Cambridge City Council will be discussing the issue at its next meeting, possibly this evening.

Photos C. Anita M. HarrisInsulators, Tin Knocker, & Pipefitters Local AFL-CIO unions protest use of non-union workers at 302 3rd St.

—Anita M. Harris

Anita Harris is a writer in Cambridge, MA.  New Cambridge Observer is a publication of the Harris Communications Group,  a marketing and public relations firm based in Kendall Square, Cambridge.

It’s not that often that I leave an art exhibit with a new way of  seeing the world, but that’s what happened after I visited the ICA’s dance/draw exhibit, last weekend.

As described in an ICA press release, the show, ” organized by  ICA Chief Curator Helen Molesworth,  traces the journey of the line from changes in drawing in the 1960s to its explosion off the page and into three-dimensional space—ultimately finding itself in the realm of dance.  It  features  some 100 works—including video, photography, drawings and sculptural objects and  live performances.”

Based on the ICA Website’s  rather  formal description ( “In both dance and drawing, the line, as an independent means of expression, was liberated from the historical ideal of perfect form, to become a  mobile, open-ended element used to explore history, memory, and the expressive potential of the body”)   I thought the show would  dry and difficult–which is why I managed to avoid seeing it until just before the exhibit closes- on January 16.  And am I sorry!  Because what I found was a  refreshing new way of experiencing both dance and drawing–as well as objects and movement in the real world–that I’d like to go back to again and again.

One section of the exhibit shows how artists used body parts and objects rather than traditional drawing implements to make art. For example,  Janine Antoni used her eyelashes and mascara to make patterns on canvas;  Trisha Brown’s superimposed  tracings of her feet show motion in themselves; John Cage drew with plants and seaweed; David Hammons bounced a basketball covered with dirt onto a white background,  and Mona Hatou, below, drew with her own hair dipped in hair dye.   Photos and the works themselves document the artmaking processes–which often  involved dance-like  movement. 1.

In another room, a section called “The Line in Space” includes works in which  thread, string, or wire were used to form line–off of paper or canvas.  Of this group, I especially liked the mesmorizing simplicity of  Fred Sandback’s “Untitled Sculptural Study”   hung  in space.

If I recall correctly, a thread red  acryllic yarn hung up and down from ceiling to floor to the left, blue from the wall to the red thread, and yellow parallel on the floor–forming a three-dimensional representation of a Mondrian-like grid.

I also got a new perspective on  charcoal drawing  when I encountered Cornelia Parker’s  Hanging Fire (Suspected Arson)  sculpture, which is part of the ICA’s permanent collection. Composed of chunks of charcoal hung from the ceiling on wire mesh, in this new context, the piece becomes a charcoal drawing– in space.

A third section, “Dancing,” explores challenges to traditional modern dance as dance performances were moved off the stage into  the “real world”  of streets, mountains, the subway and such.  “Babette Mangolte’s photographs and films of Judson dancers Trisha Brown and Lucinda Childs show us the dancing body, in its entirety, rigorously defining itself as a line in space…. Juan Capistran’s break dancing in a museum (below) “similarly engages dance to defy protocols of normative behavior. “2.

Finally, in the section “Drawing,”  younger artists demonstrate “how movement, performance, and drawing are ineluctably mixed… ” . 3. For example, Tseng Kwong Chi photographs  Bill T. Jones Body Painting with Keith Haring; Fiona Banner copies  life-drawing manuals, in which the figure often appears to be in flight; Silke Otto Knapp  traces photographic images of dancers  onto luminous silver-painted canvases, and  Helena Almeida has herself photographed while she is drawing.                                                         4.  

I loved these and  many other works in the exhibit–and can’t do justice to them all.   But my favorite was a video in which dancer William Forsythe explains and shows  how he as a dancer moves– over, under and around electronically superimposed lines and shapes –forming new lines, shapes and volume.    5.

The day after seeing the show, I could not help but notice  lines, shapes and volume in relation to individuals’ movement everywhere in my life.

Draw/Dance will be at the ICA through January 16, 2012, with major support  fromThe Andy Warhol Foundation for the Visual Arts, Ronald and Ronni Casty, the HBB Foundation, and Jacqueline Bernat and Adam Hetnarski.

Credits:

1.Janine Antoni (Bahamian, born 1964)
Loving Care, 1992-96
Color video, sound; 35:50 minutes
Performance on January 7, 1996, MATRIX
Gallery, Wadsworth Atheneum Museum of Art,
Hartford, CT
Courtesy of the artist and Luhring Augustine,
New York

2.Helena Almeida (Portuguese, born 1934)
O Atelier/The Studio, 1983
Black-and-white photograph
67 3/8 x 48 7/8 in.
Framed: 69 ¼ x 50 ¾ in.
Exhibition copy, courtesy of the artist

3.Juan Capistran (Mexican, born 1976)
The Breaks, 2000
Inkjet print
40 x 40 in.
Collection of the New Museum of Contemporary
Art, New York, The Altoids Curiously Strong
Collection, Gift of Altoids
4.Tseng Kwong Chi (Chinese, 1950-1990)
Bill T. Jones Body Painting with Keith Haring,
1983
Gelatin silver selenium-toned photograph
20 x 16 in.
Muna Tseng Dance Projects / Estate of Tseng
Kwong Chi and Courtesy of Paul Kasmin Galler

5.William Forsythe (American, born 1949)
Lectures from Improvisation Technologies, 2011
Color video, sound; 9:54 min.
The Forsythe Company and ZKM, Karlsruhe,
2011

–Anita M. Harris

New Cambridge Observer is a publication of the Harris Communications Group, a public relations firm located in Cambridge, MA.  Harris, its founder and president, also blogs there.